TY - JOUR
T1 - The global, regional, and national burden of inflammatory bowel diseases, 1990–2019
T2 - A systematic analysis for the global burden of disease study 2019
AU - Park, Jihye
AU - Jeong, Gwang Hun
AU - Song, Minjin
AU - Yon, Dong Keon
AU - Lee, Seung Won
AU - Koyanagi, Ai
AU - Jacob, Louis
AU - Kostev, Karel
AU - Dragioti, Elena
AU - Radua, Joaquim
AU - Cheon, Jae Hee
AU - Shin, Jae Il
AU - Smith, Lee
N1 - Publisher Copyright:
© 2023 Editrice Gastroenterologica Italiana S.r.l.
PY - 2023/10
Y1 - 2023/10
N2 - Background: In recent years, the global epidemiology of inflammatory bowel disease (IBD) has changed rapidly. Aims: We described the updated global IBD epidemiology results based on the 2019 Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Methods: We estimated the prevalence rate, death rate, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) from GBD 2019 in 195 countries and territories between 1990 and 2019. Results: The crude prevalence of IBD increased by 47% in 2019 globally. Accordingly, the age-standardized prevalence rate showed 19% decrease. The age-standardized death rates, YLDs, YLLs, and DALYs of IBD in 2019 decreased compared to those in 1990. The annual percentage change in age-standardized prevalence rate decreased most in United States and increased in East Asia and high-income Asia Pacific from 1990 to 2019. Continents with high socioeconomic index (SDI) had higher age-standardized prevalence rates compared to continents with low SDI. The 2019 age-standardized prevalence rate of high latitudes was higher than that of low latitudes in Asia, Europe, and North America. Conclusion: The observed trends and geographic variations in IBD documented in the 2019 GBD study will aid policymakers in policy, research, and investment development.
AB - Background: In recent years, the global epidemiology of inflammatory bowel disease (IBD) has changed rapidly. Aims: We described the updated global IBD epidemiology results based on the 2019 Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Methods: We estimated the prevalence rate, death rate, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) from GBD 2019 in 195 countries and territories between 1990 and 2019. Results: The crude prevalence of IBD increased by 47% in 2019 globally. Accordingly, the age-standardized prevalence rate showed 19% decrease. The age-standardized death rates, YLDs, YLLs, and DALYs of IBD in 2019 decreased compared to those in 1990. The annual percentage change in age-standardized prevalence rate decreased most in United States and increased in East Asia and high-income Asia Pacific from 1990 to 2019. Continents with high socioeconomic index (SDI) had higher age-standardized prevalence rates compared to continents with low SDI. The 2019 age-standardized prevalence rate of high latitudes was higher than that of low latitudes in Asia, Europe, and North America. Conclusion: The observed trends and geographic variations in IBD documented in the 2019 GBD study will aid policymakers in policy, research, and investment development.
KW - Epidemiology
KW - Global disease burden 2019
KW - Inflammatory bowel disease
UR - https://www.scopus.com/pages/publications/85154027771
U2 - 10.1016/j.dld.2023.04.003
DO - 10.1016/j.dld.2023.04.003
M3 - Article
C2 - 37137806
AN - SCOPUS:85154027771
SN - 1590-8658
VL - 55
SP - 1352
EP - 1359
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - 10
ER -